(S,E)-3-(2,6-dichloro-4-((4-(3-(1-((hexyl-d13)oxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acid
Lusutrombopag-d13 is a fully characterized chemical compound used as a reference standard of API Lusutrombopag. The standard offered is compliant with regulatory guidelines. Lusutrombopag-d13 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
